Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-22-010990
Filing Date
2022-10-05
Accepted
2022-10-05 17:30:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27668
2 filename2.txt TEXT-EXTRACT 1520
  Complete submission text file 0000000000-22-010990.txt   40315
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filed for) CIK: 0001611747 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)